“epizyme” Archives

in
Entry Author Date Location
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More 09/28/18 National
Working with Patients and a Fresh $80M, Fulcrum Eyes a 2019 IPO 09/05/18 Boston
Bio Roundup: Alnylam’s Moment, Read on Rebates, Skinny Plans & More 08/03/18 National
Accent Therapeutics Debuts With $40M To Target RNA Modification 05/18/18 Boston
Bio Roundup: CRISPR Tests, Parkinson’s Questions, Opioid Bills & More 04/27/18 National
FDA Pumps the Brakes on Epizyme’s Top Cancer Drug Tazemetostat 04/23/18 Boston
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Ex-Epizyme CEO’s New Startup, Fulcrum, Nabs $55M For Gene Control Drugs 07/19/16 Boston
Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More 06/24/16 National
Epizyme Touts Early Data From Key Trial Of Blood Cancer Drug 06/19/16 Boston
Stealthy MIT Spinout Ribon, Led by a Sanofi Vet, Takes Aim at Cancer 03/03/16 Boston
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
East Coast Biotech Roundup: PrecisionFDA, Avitide, Foresight & More 08/07/15 Boston
Epizyme Switches CEOs as Synageva’s Bazemore Steps in For Gould 08/05/15 Boston
Foresite Capital Keeps Late-Stage Healthcare Focus With $450M Third Fund 07/29/15 San Francisco
East Coast Biotech Roundup: Biogen, Epizyme, Armored CARS, & More 07/13/15 Boston
Epizyme Extends Celgene Cancer Deal for $10M Upfront 07/09/15 Boston
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
Epizyme Shares Climb on New Data for Cancer Drug 06/22/15 Boston
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech 04/29/15 New York
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
Epizyme Buys Back Control of Cancer Drug From Eisai For up to $110M 03/12/15 Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
Boston’s Life Science Disruptors: The Photos 10/21/14 Boston
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
Six Takeaways from Boston’s Life Science Disruptors 10/13/14 Boston
Page 1 of 4 next page »